Skip to content

Clinical trials

Phase 1/2 Pathologic Complete Response trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Phase: Phase 1/2 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20171
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Not yet recruiting1
Suspended1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Coronado Biosciences, Inc.1
National Cancer Institute (NCI)1
PrECOG, LLC.1
Synimmune GmbH1
Tang-Du Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response5
Leukemia, Myeloid, Acute3
Leukemia2
Carcinoma, Non-Small-Cell Lung1
Head and Neck Neoplasms1
Thrombocytopenia1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.